Uniqure B.V. buy melinda
Start price
27.06.17
/
50%
€5.41
Target price
18.07.17
€6.13
Performance (%)
7.52%
End price
18.07.17
€5.82
Summary
This prediction ended on 18.07.17 with a price of €5.82. The BUY prediction by melinda finished with a performance of 7.52%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Uniqure B.V. | - | - | -76.861% | -84.189% |
| iShares Core DAX® | -0.922% | -1.993% | 13.399% | 16.075% |
| iShares Nasdaq 100 | 0.371% | -0.868% | 41.541% | 46.938% |
| iShares Nikkei 225® | 2.224% | -5.187% | 20.497% | 4.643% |
| iShares S&P 500 | -0.026% | -0.918% | 30.410% | 42.418% |
According to melinda what are the pros and cons of Uniqure B.V. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Uniqure B.V. diskutieren
Gesundheit | Biotechnologie | Niederlande
Aktualisiert Phase 1/2 nach dem Kongress der Internationalen Gesellschaft für Thrombose und Hämostase (ISTH) 2017, die 11. Juli 2017. Phase - 2b - Studie zu Q3 2017 beginnen.
Stopped prediction by melinda for Uniqure B.V.
Uniqure B.V.
Start price
Target price
Perf. (%)
€19.00
27.12.21
27.12.21
-
27.12.22
27.12.22
8.55%
28.12.22
28.12.22
Could be worthwhile Investment >10% per year
Uniqure B.V.
Start price
Target price
Perf. (%)
€32.45
29.08.20
29.08.20
€40.00
04.11.21
04.11.21
-7.18%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Uniqure B.V.
Start price
Target price
Perf. (%)
€38.10
30.08.18
30.08.18
€40.59
25.02.19
25.02.19
31.53%
25.02.19
25.02.19
Could be worthwhile Investment >10% per year